What is the recommended insulin regimen for a patient with diabetes requiring insulin therapy, with specific guidelines for blood sugar management and sliding scale dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Regimen for Blood Sugar Management with Fixed Dose and Sliding Scale

For a patient requiring insulin therapy with blood sugar management guidelines, the recommended approach is a scheduled basal-bolus insulin regimen with 10 units of fixed-dose rapid-acting insulin before each meal, supplemented by correction doses according to the sliding scale provided, while strongly avoiding reliance on sliding scale insulin alone as the primary treatment strategy. 1, 2

Critical Problems with Sliding Scale Insulin as Primary Therapy

  • The sole use of sliding scale insulin (SSI) in any setting is strongly discouraged and explicitly condemned by the American Diabetes Association. 1, 2
  • Sliding scale insulin treats hyperglycemia reactively after it occurs rather than preventing it, leading to dangerous glucose fluctuations that exacerbate both hyper- and hypoglycemia. 2
  • Randomized trials consistently demonstrate that basal-bolus approaches achieve glycemic control (mean blood glucose <140 mg/dL) in 68% of patients versus only 38% with sliding scale insulin alone. 2

Recommended Insulin Regimen Structure

Fixed Dose Component (Scheduled Insulin)

  • Administer 10 units of rapid-acting insulin (such as lispro, aspart, or glulisine) subcutaneously 0-15 minutes before each of the three main meals. 3, 4
  • This fixed dose provides scheduled nutritional (prandial) coverage to manage the expected postprandial glucose rise from meals. 1, 3

Correction Dose Component (Sliding Scale)

  • Use the sliding scale ONLY as supplemental correction insulin in addition to the fixed scheduled doses, not as monotherapy: 1, 2
    • Blood glucose 61-150 mg/dL: No additional insulin needed
    • Blood glucose 151-200 mg/dL: Add 2 units
    • Blood glucose 201-250 mg/dL: Add 4 units
    • Blood glucose 251-300 mg/dL: Add 6 units
    • Blood glucose 301-350 mg/dL: Add 8 units
    • Blood glucose 351-400 mg/dL: Add 10 units

Hypoglycemia Management

  • For blood glucose 0-60 mg/dL: Treat immediately with 15 grams of fast-acting carbohydrate (such as glucose tablets, juice, or regular soda), recheck in 15 minutes, and hold the insulin dose. 3

Essential Basal Insulin Component

  • This regimen is incomplete without basal (long-acting) insulin coverage. 1, 3
  • A basal-bolus insulin regimen with basal, nutritional, and correction components is the preferred treatment for patients with good nutritional intake. 1
  • For patients requiring insulin therapy, start basal insulin at 10 units once daily or 0.1-0.2 units/kg body weight, administered at the same time each day. 3
  • The total daily insulin dose should typically be divided approximately 50% as basal insulin and 50% as prandial insulin for optimal glycemic control. 3, 2

Monitoring and Titration Requirements

  • Check blood glucose immediately before each meal to determine the correction dose needed in addition to the fixed 10 units. 3
  • Target premeal blood glucose of 80-130 mg/dL and postprandial glucose <180 mg/dL. 1, 5
  • If correction doses are frequently required (more than 2-3 times per week at the same meal), increase the scheduled fixed insulin dose for that meal by 1-2 units or 10-15%. 3
  • Adjust insulin doses every 3 days based on glucose patterns to achieve glycemic targets. 3, 5

Critical Pitfalls to Avoid

  • Never rely on sliding scale insulin alone without scheduled basal and prandial insulin, as this approach is associated with clinically significant hyperglycemia and poor outcomes. 1, 2
  • Never administer rapid-acting insulin at bedtime using the sliding scale, as this significantly increases nocturnal hypoglycemia risk. 3
  • Do not continue this regimen unchanged if glucose control remains poor—adjust the fixed doses upward rather than relying solely on increasing correction doses. 2
  • If hypoglycemia occurs without clear cause, reduce the insulin dose by 10-20% immediately. 3

Foundation Therapy Considerations

  • Continue metformin unless contraindicated, as it reduces total insulin requirements and provides complementary glucose-lowering effects. 3, 4
  • Ensure the patient receives education on proper insulin injection technique, site rotation, hypoglycemia recognition and treatment, and self-monitoring of blood glucose. 3

When to Intensify Therapy

  • If fasting glucose remains ≥180 mg/dL despite this regimen, increase basal insulin by 4 units every 3 days until fasting glucose reaches 80-130 mg/dL. 3
  • If postprandial glucose consistently exceeds 180 mg/dL despite the fixed 10-unit doses, increase the fixed prandial insulin dose by 1-2 units for that specific meal. 3
  • When basal insulin exceeds 0.5 units/kg/day without achieving glycemic targets, further intensification of prandial insulin becomes more appropriate than continuing to escalate basal insulin alone. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Therapy Recommendations for Hospitalized Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Research

Type 2 Diabetes Mellitus: Outpatient Insulin Management.

American family physician, 2018

Related Questions

What is the best treatment approach for an uninsured diabetic patient with no access to insulin, living in a shelter?
What is the initial insulin dose for an adult patient with type 2 diabetes mellitus (T2DM)?
What is the best approach to initiate insulin therapy in a 50-year-old female patient with uncontrolled diabetes (A1c of 9.8%, fasting blood glucose of 247 mg/dL) and noncompliance with oral medications, considering her current weight and potential introduction of additional therapies like Mojaro (canagliflozin) in the future?
What is the appropriate initial insulin dose for a patient with type 2 diabetes mellitus (T2DM) and severe hyperglycemia?
What are the recommended insulin dosing guidelines for a patient with diabetes?
What is the best course of action for an elderly patient with new onset numbness in their right hand fingertip, which started after shoveling snow and has not improved after 1 week?
What are the initial management steps and treatment options for an adult patient with nocturia, considering potential underlying conditions such as diabetes, heart failure, or sleep apnea?
What is the appropriate differential diagnosis and management approach for a patient presenting with a hand sore?
What does an elevation in right precordial leads (V4R and V3R) on an electrocardiogram (ECG) indicate in a patient with suspected cardiac ischemia?
How soon after a kidney transplant in a patient with a history of systemic lupus erythematosus (SLE) can antinuclear antibody (ANA) levels become positive, and is 7 weeks post-transplant considered too soon?
Can an elderly patient with confusion get an ammonia level test, especially if suspected to have liver disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.